Register Here For Special Webinar:  
Thursday, July 28 @ 1 pm 

We all know how common cardiovascular disease (CVD) is in nursing homes. Beyond being the leading cause of morbidity, residents are frequently referred to emergency rooms during episodes of acute exacerbation, and many are eventually hospitalized — which leads to lost bed time.  

And we all know the common factors, too: high blood pressure, high cholesterol, smoking, obesity, and physical activity, are all familiar signs when it comes to diagnosing this chronic killer.  

But according to BASE10 Genetics, there’s a leading “uncommon factor” that, when incorporated effectively, can help drastically reduce the cost and overall effectiveness in managing and treating this chronic disease. 

Register Here For Special Webinar:  
Thursday, July 28 @ 1 pm 

According to the World Health Organization (WHO), cardiovascular diseases are not only the leading cause of death worldwide, but are strongly linked to both genetic and nutritional factors. Factors that are, unfortunately, all too “uncommon” among those traditionally being considered. 

“The stark reality is, many clinicians are over-looking this key hidden factor for managing and treating cardiovascular disease,” says BASE10’s Bethany Miller, PharmD, RPh. “Our goal is to shed some new light on the role that pharmacogenomics, in combination with Precision Nutrition, play in managing overall heart health, diagnosis and treatment of cardiovascular diseases.” 

As to the exact role and influence one’s genetic make up has on CVD outcomes, medication is just one of the areas that can be most impacted. 

“When you consider that many nursing home residents are taking 8 to 10 medications on average, it’s important to understand the effectiveness of those medications as they relate to that individual’s genetic make up,” says Miller. “The same holds true for cardiovascular disease. What works for one person doesn’t necessarily make it effective for the other. There’s no ‘one-size-fits-all’ approach that’s best for every body. And by that, I mean, every person’s body.” 

Joining Miller as co-host for the webinar will be BASE10’s Dietitian and Nutrition Program Manager, Stephanie Ineman, MS, RDN, LDN.  Ineman will address the influence, role, and impact proper diet and nutrition play at the gene level. 

“One of the most exciting benefits of Precision Nutrition is understanding the direct and significant impact your diet has on your body,” says Ineman. “You can’t just look at a diagnosis to determine what food a resident should be eating.  There are many other factors that come into play, and choosing the wrong foods can lead to detrimental outcomes.” 

To learn more, just click here to register for BASE10’s upcoming Cardiovascular Disease webinar. 

About BASE10 Genetics
Located in Chicago, BASE10 is a healthcare software technology company whose platform creates turnkey disease management programs that can be deployed at scale for nursing home operators, pharmacies, payors, and self-funded employers.